Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors

Isabelle Ligi1, Stéphanie Simoncini, Edwige Tellier

  • 1Department of Neonatology, La Conception Hospital , Marseille , France .

Insights

Low birth weight babies exhibit impaired endothelial progenitor cell function due to antiangiogenic factors in their serum, potentially impacting future cardiovascular health.

Area of Science:

  • Neonatal research
  • Vascular biology
  • Cardiovascular health

Background:

  • Low birth weight (LBW) is a known risk factor for adult hypertension.
  • Endothelial progenitor cells (EPCs) show dysfunction in LBW neonates.
  • Investigating angiogenic factors in LBW neonates is crucial.

Purpose of the Study:

  • To determine if plasma pro- or anti-angiogenic factors are linked to EPC dysfunction in LBW neonates.
  • To explore the association between these factors and impaired angiogenesis.

Main Methods:

  • Umbilical cord blood was collected from normal and LBW neonates.
  • Endothelial colony-forming cells (ECFCs) from controls were cultured with serum from both groups.

Main Results:

  • LBW serum significantly reduced ECFC proliferation and migration.
  • VEGF levels were lower, while sVEGFR and PF4 were higher in LBW neonates.
  • Adding VEGF reversed the inhibitory effects of LBW serum on ECFCs.

Conclusions:

  • LBW infant serum contains antiangiogenic factors affecting ECFCs.
  • The VEGF/sVEGF/PF4 pathway is implicated in LBW-associated EPC dysfunction.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...